Crescent Capital BDC, Inc. filings document the regulatory record of a business development company that invests in secured debt, unsecured debt and related equity securities of private U.S. middle-market companies. Its Form 8-K reports include operating and financial results, dividend announcements, material agreements, capital-structure disclosures and other material events.
Proxy materials describe annual meeting voting matters, board governance and director elections. The filing record also identifies the company’s registered securities, including common stock listed under CCAP and exchange-listed notes, and provides formal disclosure around governance changes, shareholder matters, risk topics and financing arrangements.
Crane Capital (CCAP) reports a highly diversified investment portfolio focused on privately negotiated credit to middle-market companies. Positions span the United States, Canada, Europe and Australia across sectors such as health care equipment & services, software & services, commercial & professional services, consumer services, insurance, and retailing.
The portfolio is predominantly structured as unitranche and senior secured first-lien term loans and revolvers, often with delayed-draw features and contractual floors on floating-rate benchmarks such as SOFR or other reference rates. Stated cash interest spreads generally range from the mid-400s to 700 basis points over the reference rate, with many loans including PIK (paid-in-kind) components, pushing all-in coupons frequently into the high single digits to low-to-mid teens. Maturities and revolver commitment expirations extend broadly from 2026 through the early 2030s, providing a long-dated stream of contractual cash flows. The company also lists foreign currency exchange contracts with Wells Fargo Bank, N.A. and interest rate swaps with Goldman Sachs Bank USA that hedge its unsecured notes, in which CCAP receives fixed rates and pays SOFR plus a spread, indicating use of derivatives to manage interest-rate and currency risk.
Crescent Capital BDC, Inc. prepaid its 7.54% senior unsecured notes ahead of maturity. The company paid approximately $51.6 million, covering the $50.0 million aggregate principal amount plus accrued and unpaid interest, to retire notes that were due on July 28, 2026. After this transaction, none of these notes remain outstanding, meaning this specific debt obligation has been fully eliminated.
Crescent Capital BDC, Inc. increased borrowing capacity under its senior secured revolving credit facility with Sumitomo Mitsui Banking Corporation. Dollar commitments under the SMBC Corporate Revolving Facility rose from $140 million to $165 million, and the maximum principal amount increased from $310 million to $335 million. All other terms of the facility remained unchanged.
Crescent Capital BDC, Inc. updated its borrowing and note financing structure. A subsidiary entered a Ninth Amendment with Wells Fargo that increases its credit facility size from $400.0 million to $500.0 million, slightly raises the interest spread from 1.95% to 2.00%, extends the reinvestment period to May 21, 2029 and the stated maturity to May 21, 2031, and reduces the non-usage fee from 0.50% to 0.35%.
The company also completed previously announced private note issuances, including $50.0 million of Tranche C senior unsecured notes bearing 5.97% interest and maturing on May 22, 2029. In connection with these actions, on May 22, 2026 the company repaid $111.6 million of FCRX 5.00% unsecured notes in full, signaling a shift in its debt mix and maturity profile.
Crescent Capital BDC, Inc. submitted a voluntary withdrawal of its 5.00% Notes due 2026 from listing and registration on the New York Stock Exchange.
The filing states the Exchange and the issuer have each complied with the relevant rules governing voluntary withdrawal under Section 12(b).
Crescent Capital BDC, Inc. president and director Henry Chung reported an open‑market purchase of 4,500 shares of common stock at $11.45 per share on May 21, 2026. Following this transaction, he directly holds 20,722 shares, including 945 shares acquired through dividend reinvestment in 2026.
Crescent Capital BDC, Inc. Chief Executive Officer Jason Breaux bought additional company stock in an open-market transaction. On May 20, 2026, he purchased 5,000 shares of Common Stock at $11.19 per share. Following this purchase, his direct holdings increased to 52,636 shares of Crescent Capital BDC, Inc. Common Stock.
Crescent Capital BDC, Inc. Chief Financial Officer Gerhard Lombard bought 1,000 shares of common stock in an open-market purchase at $11.12 per share on 2026-05-18. This is a direct ownership transaction.
After this trade, Lombard directly owns 37,373 common shares. This figure includes 2,088 shares acquired through dividend reinvestment in 2026, which were not previously reported under Rule 16a-11.
Crescent Capital BDC, Inc. director Steven F. Strandberg reported an indirect open-market purchase of common stock through the Diana and Steven Strandberg Revocable Trust. On May 19, 2026, the trust bought 85,000 shares at a weighted average price of $11.2763 per share in multiple trades priced between $11.11 and $11.35. Following these transactions, the trust’s indirect holdings attributed to Strandberg increased to 201,135 shares of Crescent Capital BDC common stock.
Crescent Capital BDC, Inc. held its 2026 annual stockholder meeting, where 36,969,285 common shares were entitled to vote as of March 18, 2026. Stockholders elected Susan Yun Lee and Michael S. Segal as Class II directors to terms running through the 2029 annual meeting. Lee received 17,107,252 votes for, 306,098 against, and 107,901 abstentions. Segal received 16,302,024 votes for, 1,113,132 against, and 106,095 abstentions. Shareholders also ratified Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with 26,529,354 votes for, 211,437 against, and 155,426 abstentions.